NCT01213849 - Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 4, 2010

Primary Completion Date

November 25, 2010

Study Completion Date

November 25, 2010

Conditions

Asthma

Interventions

DRUG

Fluticasone furoate 50 mcg (4 inhalations)

4 inhalations of 50 mcg strength

DRUG

Fluticasone furoate 100 mcg (4 inhalations)

4 inhalations of 100 mcg strength

DRUG

Fluticasone furoate 200 mcg (4 inhalations)

4 inhalations of 200 mcg strength

DRUG

Vilanterol 25 mcg (4 inhalations)

4 inhalations of 25 mcg strength

Trial Locations (1)

GSK Investigational Site, London